Kristian Humer

Director at Sensei Biotherapeutics

Capital raised by Sensei Biotherapeutics

$348.9M+$348.9M latest round

1 Form D filing · first filed Feb 2026 · Rockville, MD

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

Sensei BiotherapeuticsBiotech · Rockville, MDsince Feb 2026

Director

Listed on Sensei Biotherapeutics's Form D filings

Company filings

via EDGAR · Form D for Sensei Biotherapeutics1

DateCompanyFormAmountRole on filing

Feb 17, 2026Sensei BiotherapeuticsForm D+$348.9M—

Form DFeb 17, 2026 · Sensei Biotherapeutics+$348.9Mnot a signer

Overview

Last filing Feb 17, 2026

Kristian Humer is on file as Director at Sensei Biotherapeutics in Rockville, MD. Sensei Biotherapeutics has 1 Form D filing on record, $348.9M raised in total.

Teammates

Sensei Biotherapeutics · 1

Christopher GerryPresident and Principal Executive OfficerSigner

Products

Sensei Biotherapeutics · 1

PIKTORPathway Inhibitor

Acquired through the acquisition of Faeth Therapeutics, PIKTOR is Sensei's lead clinical program. It is an investigational multi-node inhibitor that targets the PI3K/AKT/mTOR cellular pathway, a critical pathway involved in cancer cell growth and survival. The company is developing it for the treatment of endometrial and breast cancer.